A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: colesevelam HCL. Current diabetes reports [Curr Diab Rep] Journal article

Title	A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: colesevelam HCL.
Author(s)	Goldberg RB
Institution	Division of Endocrinology, Diabetes and Metabolism, Diabetes Research Institute, University of Miami Miller School of Medicine, 1450 Northwest 10th Avenue, Miami, FL 33136, USA. rgoldber@med.miami.edu
Source	Curr Diab Rep 2009 Oct; 9(5):331-2.
Language	eng
Pub Type(s)	Journal Article
PubMed ID	19793501

Advertise on this site.